Omyaa Pharmaceuticals Private Limited

Omyaa Pharmaceuticals Private Limited

Founded in 2020 headquartered in Delhi, India.
2020 | South West Delhi, Delhi (India) | Active

Last Updated:

October 26, 2024
HomeCompanyOmyaa Pharmaceuticals Private Limited

Who are the key members and board of directors at Omyaa Pharmaceuticals?

Board Members(3)

NameDesignationAppointment DateStatus
Rakesh Roushan In Director 27-Jul-2022Current
Om Prakash In Director 19-Oct-2020Current
Shailesh Verma In Director 19-Oct-2020Current

Financial Performance of Omyaa Pharmaceuticals.

Omyaa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20% increase. The company also saw a substantial improvement in profitability, with a 43.12% increase in profit. The company's net worth dipped by a decrease of 8.65%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
20.00%
Revenue from Operations
20.00%
Total Assets
-3.81%
Profit or Loss
43.12%
Net Worth
-8.65%
EBITDA
-112.79%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Omyaa Pharmaceuticals?

Omyaa Pharmaceuticals has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Omyaa Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Omyaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Omyaa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Director Appointment

    Rakesh Roushan was appointed as a Director was appointed as a Director on 27 Jul 2022 & has been associated with this company since 2 years 5 months .

    27 Jul 2022

  • Director Appointment

    Om Prakash was appointed as a Director was appointed as a Director on 19 Oct 2020 & has been associated with this company since 4 years 2 months .

    19 Oct 2020

  • Director Appointment

    Shailesh Kumar Verma was appointed as a Director was appointed as a Director on 19 Oct 2020 & has been associated with this company since 4 years 2 months .

    19 Oct 2020

  • Company Incorporation

    Omyaa Pharmaceuticals Private Limited was registered on 19 Oct 2020 with Roc Delhi & aged 4 years 2 months as per MCA records.

    19 Oct 2020

Frequently asked questions

  • Omyaa Pharmaceuticals Private Limited was incorporated on 19 Oct 2020.

  • The authorized share capital of Omyaa Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Omyaa Pharmaceuticals Private Limited.

    • Rakesh Roushan
    • Om Prakash
    • Shailesh Kumar Verma
  • As per Ministry of Corporate Affairs (Mca), the registered address of Omyaa Pharmaceuticals Private Limited is Plot- Kh No.26/4 Pp No.9 Pankaj Garden Qutub Vihar Phase-1, Najafgarh India, Delhi, 110071.

  • The corporate identification number (CIN) of Omyaa Pharmaceuticals Private Limited is U74999DL2020PTC371821 and the company number is 371821 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Omyaa Pharmaceuticals Private Limited has been consistent by 20.00%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Omyaa Pharmaceuticals Private Limited has experienced an downturn of -8.65%.

  • The most recent Balance Sheet for Omyaa Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development